| Not Yet Recruiting | Near-Infrared Fluorescence Imaging With Indocyanine Green to Evaluate Bowel Anastomoses in Gynecologic Oncolog NCT06871787 | Istanbul University | Phase 4 |
| Not Yet Recruiting | Emergence of Bacterial Resistance to Antibiotics in the Digestive Microbiota of Patients Treated With Anticanc NCT07093593 | Centre Georges Francois Leclerc | N/A |
| Recruiting | IDOV-Immune for Advanced Solid Tumors NCT06910657 | ViroMissile, Inc. | Phase 1 |
| Recruiting | Ivonescimab Combined With Paclitaxel and Cisplatin as Neoadjuvant Therapy Followed by Type A Hysterectomy in S NCT07130240 | Obstetrics & Gynecology Hospital of Fudan University | Phase 2 |
| Enrolling By Invitation | Primary HPV Self-Collection in Indonesia NCT06942286 | Dharmais National Cancer Center Hospital | N/A |
| Active Not Recruiting | A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations NCT07038369 | Atavistik Bio, Inc | Phase 1 |
| Recruiting | Minimally Invasive Pelvic Exenteration in Vaginal or Cervical Cancer Recurrence NCT06867445 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | N/A |
| Recruiting | Neoadjuvant Immunochemotherapy for Locally Advanced Cervical Cancer: a Prospective, Single-arm, Phase II Clini NCT07003620 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Phase 2 |
| Active Not Recruiting | Advancing Cervical Cancer Screening Through the Emergency Department - IIS NCT06796738 | University of Rochester | N/A |
| Recruiting | Phase II Trial Comparison of 3 vs 4 Fractions (BRACHY-FIT). NCT07022470 | Stanford University | Phase 2 |
| Not Yet Recruiting | Revisiting the Concept of Nerve Sparing Radical Hysterectomy NCT06999824 | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | — |
| Active Not Recruiting | Self-sampling for HPV Screening NCT07273383 | Université de Sherbrooke | N/A |
| Active Not Recruiting | Effectiveness and Impact of the Lived Experience Cancer Awareness Campaign on Screening Participation NCT06874985 | International Agency for Research on Cancer | N/A |
| Not Yet Recruiting | Effects of Health Education on Knowledge, Attitude and Screening for Cervical Cancer in Women NCT06929234 | Ordu University | N/A |
| Not Yet Recruiting | Remote Resilience: Novel Applications of mHealth in Nicaragua's Cancer Control Program NCT06921798 | University of Virginia | N/A |
| Completed | Negative HPV Test Results on Infinity/GeneXpert® With the Presence of a Late Amplification Signal: What Does T NCT06919627 | University Hospital, Brest | — |
| Recruiting | Iparomlimab and Tuvonralimab Combined With Paclitaxel and Cisplatin as Neoadjuvant Therapy for CC NCT06878222 | Obstetrics & Gynecology Hospital of Fudan University | Phase 2 |
| Withdrawn | A Clinical Study Comparing Chemotherapy Combined With PD-1 Inhibitor Versus Concurrent Chemoradiotherapy in Ce NCT06866951 | Women's Hospital School Of Medicine Zhejiang University | Phase 2 / Phase 3 |
| Recruiting | Use Misoprostol to Optimize Prevention of Cervical Cancer NCT06669533 | University of Alabama at Birmingham | N/A |
| Completed | The Effect of Motivational Interviewing on HPV-DNA Testing NCT06662136 | Muazez küçükkaya | N/A |
| Recruiting | Validation of a Lab-free Low-cost Screening Test for Prevention of Cervical Cancer NCT06815939 | DL Analytics | N/A |
| Completed | GYNecologic Cancer-Related COGnitive Impairment NCT06662435 | Northwestern University | N/A |
| Completed | A Study to Investigate the Prevalence of Human Epidermal Growth Factor Receptor 2 (HER2) Immunohistochemistry NCT06925113 | Daiichi Sankyo | — |
| Recruiting | Unidos Contra el VPH NCT06825689 | University of Texas at Austin | N/A |
| Not Yet Recruiting | A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in t NCT06724263 | Tasly Biopharmaceuticals Co., Ltd. | Phase 2 |
| Recruiting | Serplulimab With Chemoradiotherapy for Postoperative Cervical Cancer With Risk Factors NCT06727617 | Tianjin Medical University Cancer Institute and Hospital | Phase 2 |
| Not Yet Recruiting | Tolerance and Effectiveness of C14 on HPV Infection NCT06672653 | MGB Pharma | Phase 1 / Phase 2 |
| Recruiting | Nurse-led Primary Healthcare Intervention Model in Women's Health Management in Hong Kong NCT06628388 | The University of Hong Kong | N/A |
| Enrolling By Invitation | Effect of Nurse Navigation Program on Cervical Cancer Screening Behaviour of the Women Aged 30-65 NCT06647992 | TURKAN OZDAS | N/A |
| Active Not Recruiting | Sentinel Lymph Node (SLN) Mapping with Charcoal Carbon Dye in Early Stage Cervical Cancer NCT06697054 | Istanbul University | N/A |
| Active Not Recruiting | Toripalimab for High-risk Locally Advanced Cervical Cancer NCT06416696 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Phase 2 |
| Recruiting | The Effects of Immunonutrition Therapy on Locally Advanced Cervical Cancer Patients NCT06349148 | SHUANG ZHENG JIA, PhD | N/A |
| Recruiting | Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments NCT06799637 | Evopoint Biosciences Inc. | Phase 1 / Phase 2 |
| Enrolling By Invitation | Establishment and Validation of Prediction Model of Simultaneous Chemoradiotherapy for Cervical Cancer Organoi NCT06786780 | Chongqing University Cancer Hospital | Phase 2 |
| Completed | Sexual Health Integration in Treatment of Gynecological Oncology NCT06958068 | Medical University of Silesia | — |
| Recruiting | A Beta-only IL-2 ImmunoTherapY Study NCT05086692 | Medicenna Therapeutics, Inc. | Phase 1 / Phase 2 |
| Completed | Third-Generation Nanopore HPV Integration Site for Precise Prediction of Cervical Cancer Prognosis NCT06644677 | Peking Union Medical College Hospital | — |
| Completed | Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females NCT03676101 | Shanghai Bovax Biotechnology Co., Ltd. | Phase 1 |
| Completed | Quality Control of Colposcopy Application NCT06823817 | Peking Union Medical College Hospital | — |
| Completed | Impact of HPV Vaccination Against Cervical Lesions and Genital Warts in Colombia. an Ecological Assessment NCT06700941 | Universidad Nacional de Colombia | — |
| Completed | A Study of V503, a 9-valent Human Papillomavirus (9vHPV) Vaccine in Females 12-26 Years of Age Who Have Previo NCT01047345 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | A Study of V503 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Preadolesce NCT00943722 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | Combination Chemotherapy Consisting of Pegylated Liposomal Doxorubicin and Carboplatin in Malignant Gynecologi NCT00189410 | AGO Study Group | Phase 2 |
| Completed | Weekly Versus Three-week Chemoradiation in Patients With Advanced Cervical Cancer NCT01097252 | Korea Cancer Center Hospital | Phase 3 |